Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL) Meeting Abstract
| Authors: | Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; Abrey, L. E.; Sauter, C. S. |
| Abstract Title: | Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009801564 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.2008 |
| Notes: | Meeting Abstract: 2008 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
